Literature DB >> 21963004

Effective tobacco control is key to rapid progress in reduction of non-communicable diseases.

Stanton Glantz1, Mariaelena Gonzalez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21963004      PMCID： PMC3260384          DOI： 10.1016/S0140-6736(11)60615-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  31 in total

1.  Economic evaluation and the postponement of health care costs.

Authors:  Pieter H M van Baal; Talitha L Feenstra; Johan J Polder; Rudolf T Hoogenveen; Werner B F Brouwer
Journal:  Health Econ       Date:  2011-04       Impact factor: 3.046

2.  Reduction in hospital admissions for acute coronary syndrome after the successful implementation of 100% smoke-free legislation in Argentina: a comparison with partial smoking restrictions.

Authors:  D Ferrante; B Linetzky; M Virgolini; V Schoj; B Apelberg
Journal:  Tob Control       Date:  2011-05-20       Impact factor: 7.552

3.  Health and economic implications of a tobacco-free society.

Authors:  K E Warner
Journal:  JAMA       Date:  1987-10-16       Impact factor: 56.272

4.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

5.  Tobacco spending and children in low income households.

Authors:  G W Thomson; N A Wilson; D O'Dea; P J Reid; P Howden-Chapman
Journal:  Tob Control       Date:  2002-12       Impact factor: 7.552

6.  Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease.

Authors:  C M Fichtenberg; S A Glantz
Journal:  N Engl J Med       Date:  2000-12-14       Impact factor: 91.245

Review 7.  Hungry for tobacco: an analysis of the economic impact of tobacco consumption on the poor in Bangladesh.

Authors:  D Efroymson; S Ahmed; J Townsend; S M Alam; A R Dey; R Saha; B Dhar; A I Sujon; K U Ahmed; O Rahman
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

8.  Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke.

Authors:  J M Lightwood; S A Glantz
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

9.  Socioeconomic status and tobacco expenditure among Australian households: results from the 1998-99 Household Expenditure Survey.

Authors:  M Siahpush
Journal:  J Epidemiol Community Health       Date:  2003-10       Impact factor: 3.710

10.  Association of the California tobacco control program with declines in lung cancer incidence.

Authors:  Joaquin Barnoya; Stanton Glantz
Journal:  Cancer Causes Control       Date:  2004-09       Impact factor: 2.506
View more
  33 in total

Review 1.  Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.

Authors:  Abhishek Sharma; Saurabh Thakar; Carl J Lavie; Jalaj Garg; Parasuram Krishnamoorthy; Ondrej Sochor; Armin Arbab-Zadeh; Edgar Lichstein
Journal:  Curr Cardiol Rep       Date:  2015-01       Impact factor: 2.931

Review 2.  The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries.

Authors:  Sungkyu Lee; Pamela M Ling; Stanton A Glantz
Journal:  Cancer Causes Control       Date:  2012-02-28       Impact factor: 2.506

3.  An international Delphi consensus study to define motivational communication in the context of developing a training program for physicians.

Authors:  Anda I Dragomir; Vincent Gosselin Boucher; Simon L Bacon; Claudia Gemme; Geneviève Szczepanik; Kimberly Corace; Tavis S Campbell; Michael T Vallis; Gary Garber; Codie Rouleau; Doreen Rabi; Jean G Diodati; William Ghali; Kim L Lavoie
Journal:  Transl Behav Med       Date:  2021-03-16       Impact factor: 3.046

4.  Investment incentives and the implementation of the Framework Convention on Tobacco Control: evidence from Zambia.

Authors:  Raphael Lencucha; Jeffrey Drope; Ronald Labonte; Richard Zulu; Fastone Goma
Journal:  Tob Control       Date:  2015-07-01       Impact factor: 7.552

5.  Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset.

Authors:  Romain Rey; Thierry D'Amato; Laurent Boyer; Lore Brunel; Bruno Aouizerate; Fabrice Berna; Delphine Capdevielle; Isabelle Chereau; Gabrielle Chesnoy-Servanin; Hélène Denizot; Jean-Michel Dorey; Caroline Dubertret; Julien Dubreucq; Catherine Faget; Franck Gabayet; Christophe Lancon; Jasmina Mallet; David Misdrahi; Christine Passerieux; Aurélie Schandrin; Franck Schürhoff; Mathieu Urbach; Pierre Vidailhet; Pierre-Michel Llorca; Guillaume Fond
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-07       Impact factor: 5.270

6.  Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.

Authors:  Edward J Mills; Kristian Thorlund; Shawn Eapen; Ping Wu; Judith J Prochaska
Journal:  Circulation       Date:  2013-12-09       Impact factor: 29.690

7.  SMOKEFREE AIR: AN IMPORTANT STRATEGY TO REDUCING HEART ATTACKS AROUND THE WORLD.

Authors:  Crystal E Tan; Stanton A Glantz
Journal:  Glob Heart       Date:  2012-07

8.  Health preemption behind closed doors: trade agreements and fast-track authority.

Authors:  Eric Crosbie; Mariaelena Gonzalez; Stanton A Glantz
Journal:  Am J Public Health       Date:  2014-07-17       Impact factor: 9.308

9.  Hospital admissions for acute myocardial infarction before and after implementation of a comprehensive smoke-free policy in Uruguay.

Authors:  Ernesto Marcelo Sebrié; Edgardo Sandoya; Andrew Hyland; Eduardo Bianco; Stanton A Glantz; K Michael Cummings
Journal:  Tob Control       Date:  2012-02-15       Impact factor: 7.552

10.  Increased cigarette tax is associated with reductions in alcohol consumption in a longitudinal U.S. sample.

Authors:  Kelly C Young-Wolff; Karin A Kasza; Andrew J Hyland; Sherry A McKee
Journal:  Alcohol Clin Exp Res       Date:  2013-08-09       Impact factor: 3.455
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.